Medline Inc. june 15, 2026 Please complete the form below to contact Kaplan Fox regarding the Medline Inc. Investigation: Join a Case First Name * Last Name * Email Address * Phone Number * Ticker Symbol Or Company Name * Please Insert Your Estimation Of Losses In USD * Are you a current or former employee of the company mentioned having traded above? * Yes No Captcha Submit If you are human, leave this field blank. Principal Contacts Pamela MayerPMayer@kaplanfox.comLaurence D. KingLKing@kaplanfox.com Kaplan Fox Alerts Investors of Medline Inc. (NASDAQ: MDLN) to an Investigation of Potential Securities Law Violations Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN). CLICK HERE TO JOIN THE CASE If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing pmayer@kaplanfox.com or by calling (646) 315-9003. On June 2, 2026, the Federal Drug Administration (“FDA”) published a warning letter dated May 28, 2026 addressed to Medline summarizing “significant violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals[.]” The FDA further states that Medline “failed to thoroughly investigate any unexplained discrepancy or failure of a batch or any of its components to meet any of its specifications.” Following this news, the price of Medline stock fell $2.56 per share, or 7.16%, to close at $33.19 per share on June 2, 2026. According to a June 3, 2026 Reuters article, the latest FDA warning letter relates to “violations of manufacturing quality standards” and is “the second such action against the [C]ompany in two months.” Further, the Reuters article states that according to the FDA, “the Company failed to thoroughly investigate microbial contamination incidents in finished drug products and also cited inadequate cleaning practices.” WHY CONTACT KAPLAN FOX Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Past results do not guarantee future outcomes. If you have any questions about this Notice, your rights, or your interests, please contact: CONTACT:Pamela A. MayerKAPLAN FOX & KILSHEIMER LLP800 Third Avenue, 38th FloorNew York, New York 10022(646) 315-9003pmayer@kaplanfox.com Laurence D. KingKAPLAN FOX & KILSHEIMER LLP1999 Harrison Street, Suite 1501Oakland, California 94612(415) 772-4704lking@kaplanfox.com The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client. Any information you submit will be maintained as confidential. If Kaplan Fox, in its sole discretion, believes that you might be an appropriate client, Kaplan Fox will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases. Connect with Kaplan Fox. Receive a complimentary case review now. Contact Us Medline Inc. Class Action Alert: Learn More Now See the Case Verra Mobility Corporation Class Action Alert: Learn More Now See the Case PicS N.V. Class Action Alert: Learn More Now See the Case Fulcrum Therapeutics, Inc. Investigation: Learn More Now See the Case Lucid Group, Inc. Class Action Alert: Learn More Now See the Case AeroVironment, Inc. Class Action Alert: Learn More Now See the Case Zoetis, Inc. Class Action Alert: Learn More Now See the Case Veritone, Inc. Class Action Alert: Learn More Now See the Case FS KKR Capital Corp. Class Action Alert: Learn More Now See the Case Sportradar Group AG Shareholder Alert: Learn More Now See the Case Badger Meter, Inc. Shareholder Alert: Learn More Now See the Case Simply Good Foods Shareholder Alert: Learn More Now See the Case
